- Udyam number
- UDYAM-HR-13-0010220

About Viva Drugs Private Limited
Data last updated:
Viva Drugs Private Limited is a private limited company based in Khamano, Punjab, India, a subsidiary of Ultra Drugs Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 January 1996 and has been in existence for over 30 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24231PB1996PTC017590. Its GSTIN is 03AABCV1403E3Z3 (Punjab). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹4.92 Cr. It was formerly known as Viva Drugs Limited. It is led by directors including Minna Jakhar and Sonali Dalla.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Village Phirour Khamano – Khanna Road Teh. Khamano, Punjab, India – 141801.
As per the financials filed for FY 2025, the company reported a revenue of ₹10.8 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹1.83 Lakh (net margin 0.2%) and EBITDA of ₹90.62 Lakh (EBITDA margin 8.4%). Revenue has grown at a compounded annual rate (CAGR) of 577% over three years and 525% over five years.
The company is associated with 1 brand: Viva Drugs. As per MCA filings, the company has open charges of ₹4.65 Cr and satisfied charges of ₹2.13 Cr on record. Court records list 3 cases involving the company, including 1 filed by the company and 2 filed against it; 2 cases are pending.
Viva Drugs Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-HR-13-0010220). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vivadrugs.com.
Company details
CIN history
Viva Drugs has one previous CIN (Corporate Identification Number): U24231PB1996PLC017590. The current CIN is U24231PB1996PTC017590, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24231PB1996PTC017590 | Current |
| U24231PB1996PLC017590 | Previous |
Recognitions & Rankings of Viva Drugs
Contact details
Viva Drugs Private Limited's registered office is in Khamano, Punjab. Its website is vivadrugs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressVillage Phirour Khamano – Khanna Road Teh. Khamano, Punjab, India – 141801
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Viva Drugs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Viva Drugs operates one associated brand: Viva Drugs. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing of APIs, pharma intermediates, and specialty chemicals in India. | vivadrugs.com |
Business activity
The main business activity of Viva Drugs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Viva Drugs Private Limited, buy the company report.
Financials of Viva Drugs Private Limited
FY 2025 filings availableViva Drugs Private Limited reported revenue of ₹10.8 Cr (up 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 525% over five years, including 3% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹90.62 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.83 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.4% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Viva Drugs Private Limited, buy the company report.
Board of directors of Viva Drugs Private Limited
Viva Drugs has 3 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Minna Jakhar Also directs: Ultra Drugs Private Limited, Apus Life Private Limited, Ultra Bytes Private Limited and 2 more | Director | 17 Jul 2020 | 6 Years 4 Months | Current |
| Sonali Dalla | Director | 17 Jul 2020 | 6 Years 4 Months | Current |
| Sangram Singh Also directs: Ultra Drugs Private Limited, Ultra Bytes Private Limited, Ultra Drugs Formulations Private Limited and 1 more | Director | 30 Sep 2025 | 1 Years 1 Months | Current |
Peer comparison
Viva Drugs Private Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Meha Pharma Private Limited | ₹11.43 Cr (FY 2024) | Mumbai, Maharashtra, India | ||||
| Sodum Drugs and Pharmaceuticals Private Limited | ₹11.15 Cr (FY 2022) | 485.0% | Medak, Telangana, India | |||
| Leedskem (India) Limited | ₹10.95 Cr (FY 2024) | 159.0% | Jalgaon, Maharashtra, India | |||
| Iris Pharmachem (India) Private Limited | ₹10.84 Cr (FY 2025) | 9.0% | Ahmedabad, Gujarat, India | |||
| Viva Drugs Private Limitedthis company | ₹10.8 Cr (FY 2025) | ₹1.83 Lakh | 0.2% | 3.0% | Khamano, Punjab, India | |
| Ven Life Sciences Private Limited | ₹10.79 Cr (FY 2025) | 782.0% | Hyderabad, Telangana, India | |||
| SRV Biosciences Private Limited | ₹10.41 Cr (FY 2025) | 495.0% | Hyderabad, Telangana, India | |||
| Vani Organics Private Limited | ₹10.35 Cr (FY 2022) | -40.0% | Bidar, Karnataka, India | |||
| Sindhu Organics Private Limited | ₹10.08 Cr (FY 2025) | -23.0% | Navi Mumbai, Maharashtra, India | |||
| Deesha Organic Private Limited | ₹10.06 Cr (FY 2025) | -9.0% | Vadodara, Gujarat, India |
To see the full peer comparison of Viva Drugs Private Limited, buy the company report.
Auditor
Viva Drugs Private Limited is audited by GAURAV RAMESH BANSAL & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GAURAV RAMESH BANSAL & CO | FY 2023 | 025649N |
Shareholding
The shareholding of Viva Drugs Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Viva Drugs Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Jan 2023 | 100709085 | State Bank of India | ₹4.65 Cr | Open | |
| 09 Aug 2002 | 90174104 | Indian Overseas Bank | ₹1.48 Cr | Satisfied | |
| 23 Jul 2002 | 90175317 | Indian Overseas Bank | ₹32.39 Lakh | Satisfied | |
| 23 Jul 2002 | 90309469 | Indian Overseas Bank | ₹32.39 Lakh | Satisfied |
To see the full charge records of Viva Drugs Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
Viva Drugs Private Limited has 3 court cases on record: 1 filed by Viva Drugs, 2 filed against it. 2 cases are pending and 1 is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 2 | 2 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Solan, Himachal Pradesh | Cheque dishonour complaint | Filed by the company against M/S Markans Pharma, | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (SUMMONS WARRENT CASES SW) | Filed against the company by A.S. Joshi Co. | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (SS CASES S) | Filed against the company by an individual | Disposed |
To see the full case history of Viva Drugs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Viva Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Viva Drugs Private Limited has 1 active EPFO establishment as of Nov 18, 2026.
GST
Viva Drugs has 3 GST registrations: 1 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AABCV1403E3Z3 | Punjab | Active | 29 Oct 2018 |
To see the full GST registrations and return filing status of Viva Drugs Private Limited, buy the company report.
Recent activity
Viva Drugs Private Limited has 11 board changes on record since 2008: 3 appointments and 8 cessations. The latest: Sangram Singh was appointed as Director on 30 Sep 2025.
12 earlier events are in the company report.
Frequently asked questions
Viva Drugs is an active private limited company based in Khamano, Punjab, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 January 1996 (30+ years old) and is registered under CIN U24231PB1996PTC017590.
Viva Drugs has 3 current directors:
- Minna Jakhar - Director
- Sonali Dalla - Director
- Sangram Singh - Director
The latest financial statements of Viva Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Viva Drugs is 03AABCV1403E3Z3, registered in Punjab. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Viva Drugs is U24231PB1996PTC017590. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Viva Drugs has 3 court cases on record: 1 filed by the company and 2 filed against it. 2 are pending.
Viva Drugs was incorporated on 18 January 1996, making it 30+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Viva Drugs by revenue are Meha Pharma Private Limited, Sodum Drugs and Pharmaceuticals Private Limited, Leedskem (India) Limited, Iris Pharmachem (India) Private Limited, Ven Life Sciences Private Limited and 4 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sangram Singh was appointed as Director on 30 Sep 2025. Raj Pal ceased to be Director on 10 Sep 2021. Sov Inal Sen ceased to be Director on 10 Sep 2021. Viva Drugs has 11 board changes on record in total.
Yes, Viva Drugs is registered as an MSME under Udyam registration (number: UDYAM-HR-13-0010220).
Viva Drugs can be reached through the website vivadrugs.com. Its registered office is in Khamano, Punjab, India.

